Matthew Jarpe, Phd

Matt Jarpe has over 25 years of experience in drug discovery, covering large biotech and startup companies, which includes extensive experience in oncology, neuroscience, autoimmunity and inflammation. He is a co-author on several publications and has been an active collaborator on dozens of research projects with academic scientists all over the world. Over the years working as a biotechnology drug hunter, he has researched treatments for rare diseases, including Progressive Supranuclear Palsy, Sickle Cell Disease, Beta Thalessemia, Charcot-Marie-Tooth disease, inborn errors of metabolism, and Alpha one antitrypsin deficiency. He currently acts as a scientific advisor to patient advocacy and rare disease organizations, helping them to align their strategic goals with academic and industry research.